GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » Gross Margin %
中文

BioLife Solutions (STU:BJX1) Gross Margin %

: 28.26% (As of Dec. 2023)
View and export this data going back to 2017. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. BioLife Solutions's Gross Profit for the three months ended in Dec. 2023 was €8.5 Mil. BioLife Solutions's Revenue for the three months ended in Dec. 2023 was €30.0 Mil. Therefore, BioLife Solutions's Gross Margin % for the quarter that ended in Dec. 2023 was 28.26%.

Warning Sign:

BioLife Solutions Inc gross margin has been in long-term decline. The average rate of decline per year is -16.9%.


The historical rank and industry rank for BioLife Solutions's Gross Margin % or its related term are showing as below:

STU:BJX1' s Gross Margin % Range Over the Past 10 Years
Min: 31.09   Med: 57.58   Max: 68.51
Current: 32.63


During the past 13 years, the highest Gross Margin % of BioLife Solutions was 68.51%. The lowest was 31.09%. And the median was 57.58%.

STU:BJX1's Gross Margin % is ranked worse than
76.76% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.54 vs STU:BJX1: 32.63

BioLife Solutions had a gross margin of 28.26% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for BioLife Solutions was -16.90% per year.


BioLife Solutions Gross Margin % Historical Data

The historical data trend for BioLife Solutions's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.00 57.07 31.09 33.27 32.63

BioLife Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.57 37.23 29.90 34.95 28.26

Competitive Comparison

For the Medical Instruments & Supplies subindustry, BioLife Solutions's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLife Solutions Gross Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Gross Margin % distribution charts can be found below:

* The bar in red indicates where BioLife Solutions's Gross Margin % falls into.



BioLife Solutions Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

BioLife Solutions's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=42.9 / 131.38
=(Revenue - Cost of Goods Sold) / Revenue
=(131.38 - 88.508) / 131.38
=32.63 %

BioLife Solutions's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=8.5 / 30.016
=(Revenue - Cost of Goods Sold) / Revenue
=(30.016 - 21.534) / 30.016
=28.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


BioLife Solutions  (STU:BJX1) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

BioLife Solutions had a gross margin of 28.26% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


BioLife Solutions Gross Margin % Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions (STU:BJX1) Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

BioLife Solutions (STU:BJX1) Headlines

No Headlines